Recent immigration, lack of partner support and pregnancy-induced hypertension are significant factors in predicting whether women will experience depressive symptoms soon after giving birth, says a University of Toronto researcher.

U of T nursing professor Cindy-Lee Dennis and colleagues at the University of British Columbia have developed a model that predicts which mothers are at high risk of developing depressive symptoms in the early postpartum period. Their study, published in the fall issue of Acta Psychiatrica Scandinavia, looked at almost 600 British Columbia mothers between April 2001 and January 2002.

Early detection is important, says Dennis, since low mood shortly after delivery is a reliable predictor of later developing postpartum depression.

"Postpartum depression is a major public health issue that has significant consequences for the mother, child and family," says Dennis. "Fortunately, postpartum depression is amenable to supportive interventions early in the postpartum period. Previous studies have identified high-risk mothers at six to eight weeks after birth. Why wait until the mothers are depressed? Why not identify symptoms early so that so secondary preventive interventions can be initiated?"

Previous research has suggested that 13 per cent of new mothers suffer from postpartum depression. Such depression may incapacitate them, but it also has a negative impact on their babies. Children of depressed mothers may exhibit attachment insecurity, emotional developmental delay and difficulties with social interaction.

The researchers identified a number of factors that make women vulnerable to depressive symptoms in the immediate postpartum period, including immigration during the five years prior to giving birth, pregnancy-induced hypertension, lack of partner support and lack of readiness for hospital discharge. The researchers also determined it is important to assess past depressive episodes, vulnerable personality traits, recent stressful life events, availability of support and maternal adjustment in identifying new mothers at risk for postpartum depression.

"The next step is to develop accessible and effective preventive and treatment plans for these women," says Dennis.

CONTACT: Cindy-Lee Dennis, Faculty of Nursing, 416-946-8608,
cindylee.dennisutoronto.ca or Elaine Smith, U of T Public Affairs, 416-978-5949, elaine.smithutoronto.ca

Contact: Cindy-Lee Dennis
416-946-8608
University of Toronto

Tag Cloud

Order Advair (Fluticasone) Without Prescription
Order Antabuse (Disulfiram) Without Prescription
Order Armour (Thyroid) Without Prescription
Order Atripla (Efavirenz) Without Prescription
Order Augmentin (Clavulanate) Without Prescription
Order Benicar (Olmesartan) Without Prescription
Order Chantix (Varenicline) Without Prescription
Order Clonidine (Catapres) Without Prescription
Order Elavil (Amitriptyline) Without Prescription
Order Erythromycin (Robimycin) Without Prescription
Order Famvir (Famciclovir) Without Prescription
Order Hydrochlorothiazide (Microzide) Without Prescription
Order Imitrex (Sumatriptan) Without Prescription
Order Inderal (Propranolol) Without Prescription
Order Lasix (Furosemide) Without Prescription
Order Lumigan (Bimatoprost) Without Prescription
Order Medrol (Methylprednisolone) Without Prescription
Order Misoprostol (Cytotec) Without Prescription
Order Naltrexone (Revia) Without Prescription
Order Nexium (Esomeprazole) Without Prescription
Order Nolvadex (Tamoxifen) Without Prescription
Order Norvasc (Amlodipine Besylate) Without Prescription
Order Ortho Tri-Cyclen (TriNessa) Without Prescription
Order Retin-A (Tretinoin) Without Prescription
Order Spiriva (Tiotropium) Without Prescription
Order Suprax (Cefixime) Without Prescription
Order Synthroid (Levothyroxine) Without Prescription
Order Ventolin (Albuterol) Without Prescription
Order Zithromax (Azithromycin) Without Prescription